Bernhard H. Weigl PhD, MSc

Bernhard Weigl is a Senior Director, of Diagnostics Research and Development at GH Labs. He is also working as a professor at the University of Washington, where he leads work to develop highly sensitive, rapid diagnostic assays for diseases of relevance in developing countries. From 2014 to 2015, he was a Senior Technology Officer with PATH and a Portfolio Leader for non-communicable disease diagnostics, and the former Director of the Center for Point-of-Care Diagnostics for Global Health. His work focuses on diagnostic technology research and development, including strip-based immunoassays, instrument-free molecular assays, and a variety of isothermal amplification assays for low-resource settings.